THC Farmaceuticals (THC Farmaceuticals) EV-to-Revenue : 107.50 (As of May. 06, 2024)

THC Farmaceuticals EV-to-Revenue Chart

THC Farmaceuticals Quarterly Data
	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Mar17	Jun17	Mar18	Jun18
EV-to-Revenue	Get a 7-Day Free Trial															350.68	1,390.52	1,080.86	1,060.68	8,980.83

Competitive Comparison of THC Farmaceuticals's EV-to-Revenue

For the Biotechnology subindustry, THC Farmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Farmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, THC Farmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where THC Farmaceuticals's EV-to-Revenue falls into.

THC Farmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

THC Farmaceuticals's EV-to-Revenue for today is calculated as:

THC Farmaceuticals's current Enterprise Value is $0.65 Mil.
THC Farmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals  (OTCPK:CBDG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

THC Farmaceuticals's PS Ratiofor today is calculated as:

THC Farmaceuticals's share price for today is $0.043.
THC Farmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of THC Farmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Farmaceuticals (THC Farmaceuticals) Business Description